RDGT (Ridgetech) Risk Assessment

View and export this data going back to 2009. Start your Free Trial

What is Ridgetech Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Ridgetech is: High Risk: High uncertainty.

Competitive Comparison of Ridgetech's Risk Assessment

For the Pharmaceutical Retailers subindustry, Ridgetech's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ridgetech's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ridgetech's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Ridgetech's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Ridgetech (NAS:RDGT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Ridgetech Risk Assessment Related Terms

Thank you for viewing the detailed overview of Ridgetech's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Ridgetech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ridgetech Inc (NAS:RDGT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

Renxin Yaju, 4th Floor, Building 5, Gong Shu District, Zhejiang Province, Hangzhou, CHN, 310014

Website

http://www.jiuzhou360.com

Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.

Executives

Wei Hu	officer: Chief Operating Officer	HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008
Pingfan Wu	director	HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008
Jiangliang He	director	HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY NY 310008
Liu Yan	officer: Secretary	HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY, ZHEJIANG PROVIN F4 310008
Lei Liu	director, 10 percent owner, officer: CEO, Chairman of the Board	ROOM 507-513, 5TH FLOOR,A BUILDING MEIDU PLAZA, GONGSHU DISTRICT HANGZHOU F4 310011
Ming Zhao	director, 10 percent owner, officer: Chief Financial Officer	1ST FLOOR, YUZHENG PLAZA, NO. 76, YUHUANGSHAN ROAD, HANGZHOU, ZHEJIANG PROVINCE F4 00000
Caroline Wang	director	HAI WAI HAI TONGXIN MANSION FLOOR 6 GONG SHU DISTRICT HANGZHOU CITY F4 310008
Hillhouse Investment Management, Ltd.	10 percent owner	OFFICE #122, WINDWARD 3 BUILDING, REGATTA OFFICE PARK, WEST BAY ROAD, GRAND CAYMAN E9 KY1-9006
Li Lei	director, 10 percent owner, officer: CEO, Chairman of the Board	511 NE 94TH STREET MIAMI SHORES FL 33138
Li Qi	director, 10 percent owner, officer: Secretary	ROOM 507-513, 5TH FLOOR, A BUILDING MEIDU PLAZA, GONGSHU DISTRICT HANGZHOU F4 310011
Zhimin Su	director	3601B THE CENTER, 989 CHANGLE ROAD SHANGHAI F4 200031
Genghua Gu	director	1ST FLOOR, YUZHENG PLAZA NO.76, YUHUANGSHAN ROAD HANGZHOU, ZHEJIANG PROVINCE F4 310002
Taihong Guo	director	7TH FLOOR, QINGCHUNBAO GROUP NO. 555 XIXI ROAD HANGZHOU F4 310013
Tchaikovsky Bennet Price Jr	other: Former Director	11601 WILSHIRE BOULEVARD, SUITE 2150, LOS ANGELES CA 90025
Marc Thomas Serrio	other: Former Director	P.O. BOX 91836 PASADENA CA 91109